Methods and compositions to graft bone using iron excipients
US-2024000996-A1 · Jan 4, 2024 · US
US10046087B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10046087-B2 |
| Application number | US-201414778656-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 21, 2014 |
| Priority date | Mar 22, 2013 |
| Publication date | Aug 14, 2018 |
| Grant date | Aug 14, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There are provided collagen based polymeric materials comprising collagen molecules and/or collagen derived molecules which have been functionalized by the addition of one or more ethylenically unsaturated moieties and which have been cross-linked via said moieties. Also provided are collagen based compositions and methods of producing collagen based polymeric materials.
Opening claim text (preview).
The invention claimed is: 1. A method of producing a collagen based polymeric material wherein the method comprises cross linking functionalised collagen and/or collagen derived molecules having one or more ethylenically unsaturated moieties, wherein the one or more ethylenically unsaturated moieties includes 4-vinylbenzyl chloride (4VBC). 2. A method according to claim 1 , wherein the method comprises the steps of: (a) Functionalising collagen and/or collagen derived molecules by the addition of one or more moieties comprising a vinyl group; and (b) Crosslinking of the functionalised collagen and/or collagen derived molecules of (a). 3. A collagen based composition comprising a functionalised collagen and/or collagen derived molecule, wherein the collagen and/or collagen derived molecule is functionalised by addition of one or more ethylenically unsaturated moieties wherein the one or more ethylenically unsaturated moieties includes 4-vinylbenzyl chloride (4VBC). 4. A method of producing a collagen based polymeric material according to claim 1 , wherein the material is produced in the form of one or more fibres and/or one or more filaments and/or one or more films and/or one or more gels and wherein the method comprises the steps of: (a) Functionalising collagen and/or collagen derived molecules with the one or more ethylenically unsaturated moieties; (b) Combining the functionalised collagen and/or collagen derived molecules with a vehicle; and (c) Wet spinning the functionalised collagen and/or collagen derived molecules. 5. A method according to claim 1 , wherein the material is produced in the form of one or more fibres and/or one or more filaments and/or one or more films and/or one or more gels and wherein the method comprises the steps of: (a) Functionalising collagen and/or collagen derived molecules with the one or more ethylenically unsaturated moieties; (b) Combining the functionalised collagen and/or collagen derived molecules with a vehicle; and (c) Wet spinning the functionalised collagen and/or collagen derived molecules; and wherein a photoinitiator is added during or after steps (b) and/or (c). 6. A method according to claim 4 , wherein the formed collagen fibres and/or filaments have a diameter of between about 0.01 μm and 50 μm. 7. A method according to claim 1 , further comprising: forming a web, a tow, a yarn, and/or a nonwoven of functionalised collagen fibres and/or filaments and/or films, wherein a pore size of the web, the tow, the yarn, and/or the nonwoven of functionalised collagen fibres and/or filaments and/or films is between about 5 μm and 350 μm. 8. A method according to claim 1 , wherein the material or composition comprises functionalised collagen which has a preserved triple helical structure. 9. A method according to claim 1 , wherein [4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone] (Irgacure® 2959) is used as a photoinitiator for cross-linking. 10. A method according to claim 1 , wherein a degree of functionalisation of the collagen is controllable and is variable between 5 mol % and 100 mol %. 11. A method according to claim 1 , wherein a compressive modulus (E) of the material is between 50 kPa and 300 kPa. 12. A method according to claim 1 , wherein a swelling ratio of the material is higher than at least 100 wt %. 13. A method according to claim 1 , wherein a degradation time of the material is higher than at least 3 days and wherein a denaturation temperature of the material is between about 60° C. and 90° C. 14. A method according to claim 1 , wherein the one or more ethylenically unsaturated moieties includes a combination of 4-vinylbenzyl chloride (4VBC) and glycidyl methacrylate (GMA). 15. A method according to claim 1 , wherein the one or more ethylenically unsaturated moieties includes a combination of 4-vinylbenzyl chloride (4VBC) and methacrylic anhydride (MA). 16. A method according to claim 5 , wherein the photoinitiator is [4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone] (Irgacure® 2959).
Characterised by the use of proteins; Derivatives thereof · CPC title
derived from leather or skin {, e.g. gelatin} · CPC title
Collagen · CPC title
derived from leather or skin · CPC title
Collagen · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.